Hospital Mater Dei SA
BOVESPA:MATD3
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.07
8.57
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MATD3 stock under the Base Case scenario is 14.43 BRL. Compared to the current market price of 4.24 BRL, Hospital Mater Dei SA is Undervalued by 71%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Hospital Mater Dei SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MATD3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Hospital Mater Dei SA
Balance Sheet Decomposition
Hospital Mater Dei SA
Current Assets | 2.1B |
Cash & Short-Term Investments | 324.6m |
Receivables | 645.8m |
Other Current Assets | 1.1B |
Non-Current Assets | 2.8B |
Long-Term Investments | 16.8m |
PP&E | 1.4B |
Intangibles | 728.3m |
Other Non-Current Assets | 660.1m |
Current Liabilities | 849.2m |
Accounts Payable | 127.5m |
Accrued Liabilities | 102.8m |
Other Current Liabilities | 618.9m |
Non-Current Liabilities | 2.5B |
Long-Term Debt | 2B |
Other Non-Current Liabilities | 557.3m |
Earnings Waterfall
Hospital Mater Dei SA
Revenue
|
2.3B
BRL
|
Cost of Revenue
|
-1.6B
BRL
|
Gross Profit
|
716.2m
BRL
|
Operating Expenses
|
-1.1B
BRL
|
Operating Income
|
-345.1m
BRL
|
Other Expenses
|
-25.6m
BRL
|
Net Income
|
-370.7m
BRL
|
Free Cash Flow Analysis
Hospital Mater Dei SA
BRL | |
Free Cash Flow | BRL |
MATD3 Profitability Score
Profitability Due Diligence
Hospital Mater Dei SA's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
Hospital Mater Dei SA's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
MATD3 Solvency Score
Solvency Due Diligence
Hospital Mater Dei SA's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Score
Hospital Mater Dei SA's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MATD3 Price Targets Summary
Hospital Mater Dei SA
According to Wall Street analysts, the average 1-year price target for MATD3 is 8.21 BRL with a low forecast of 5.35 BRL and a high forecast of 10.4 BRL.
Dividends
Current shareholder yield for MATD3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hospital Mater Dei SA engages in the provision of health care services. The company is headquartered in Belo Horizonte, Minas Gerais. The company went IPO on 2021-04-16. The firm has hospital beds distributed in its four units strategically located in the metropolitan region of Belo Horizonte and in Belem, in addition to hospital beds in the Hospital de Salvador/BA, Hospital Santa Genoveva in Uberlandia/MG, Hospital Premium in Goiania/GO and Hospital EMEC in Feira de Santana/BA. The firm provides services to several independent and self-managed health plan operators, such as: Allianz, Amil, Bacen, Bradesco Saude, Caixa Economica Federal, Care Plus, Cassi, Copass, FCA Saude, Golden Cross, IPSM, Sul America, Vale, among many others.
Contact
IPO
Employees
Officers
The intrinsic value of one MATD3 stock under the Base Case scenario is 14.43 BRL.
Compared to the current market price of 4.24 BRL, Hospital Mater Dei SA is Undervalued by 71%.